Cardio Diagnostics Secures Coverage for Precision Heart Tests with Atlas Healthcare Physicians
Summary
Cardio Diagnostics announced that Atlas Healthcare Physicians, an independent physician association in Los Angeles and Orange counties, will now cover its Epi+Gen CHD(TM) and PrecisionCHD(TM) tests for eligible members, subject to prior authorization. This is a positive development for a company that reported extremely low Q1 revenue of just $2.68K and increased losses. Expanding coverage for its precision cardiovascular tests is a critical step towards commercialization and increasing sales for the micro-cap company.
At the time of this announcement, CDIO was trading at $2.04 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $6M. The 52-week trading range was $0.97 to $7.91. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: FinanceWire.